je.st
news
Tag: application review
February 12, 2015: Washington Park Reservoir Project Initial Land Use Review Application Complete; Public Comment Period Open & Hearing Scheduled
2015-02-13 01:11:35| PortlandOnline
Tags: february
public
comment
complete
Land Use Review Application (Type IV)
2014-12-16 01:12:29| PortlandOnline
PDF Document, 6,364kbCategory: Land Use Review Application #1
Tags: type
review
land
application
Water Bureau Submits Land Use Review Application for Washington Park Reservoir Improvements Project; Public Comment Period & Hearing in January 2015
2014-12-15 23:41:52| PortlandOnline
Tags: public
january
comment
review
December 15, 2014: Land Use Review Application for Washington Park Reservoir Improvements Project; Public Comment Period & Hearing in January 2015
2014-12-15 23:41:19| PortlandOnline
Tags: in
public
january
comment
US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteurs Investigational Pediatric Hexavalent Vaccine
2014-10-20 14:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. & SWIFTWATER, Pa. Phase III clinical study data presented at IDWeek in Philadelphia WHITEHOUSE STATION, N.J. & SWIFTWATER, Pa.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies investigational pediatric hexavalent vaccine, DTaP5-IPV-Hib-HepB1, has been accepted for review by the U.S. Food and Drug Administration (FDA). Language: English Contact: MerckMedia:Deb Wambold, (215) 652-2913orInvestors:Justin Holko, (908) 423-5088orSanofi PasteurMedia:Susan Watkins, (570) 957-2563susan.watkins@sanofipasteur.comorInvestors:George Grofik, (908) 981-5560IR@sanofi.com Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more
Tags: review
application
license
accepts